(TUB) Tubize-Fin - Performance 28.4% in 12m
Compare TUB with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
46.76%
#18 in Group
Rel. Strength
82.07%
#1441 in Universe
Total Return 12m
28.35%
#31 in Group
Total Return 5y
78.92%
#24 in Group
P/E 57.3
88th Percentile in Group
P/E Forward -
(?) Percentile in Group
PEG -
(?) Percentile in Group
FCF Yield 1.65%
(?) Percentile in Group
12m Total Return: TUB (28.4%) vs XLV (0.3%)

5y Drawdown (Underwater) Chart

Top Performers in Pharmaceuticals
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
---|---|---|---|---|---|---|---|---|
CORT NASDAQ Corcept Therapeutics |
23% | 223% | 432% | 50.6 | 37.7 | 0.61 | 61.4% | 10.7% |
LLY NYSE Eli Lilly |
3.78% | 22.8% | 483% | 71.9 | 36.8 | 1.22 | 40.3% | 34.5% |
NVS NYSE Novartis |
1.59% | 17.3% | 62% | 18.9 | 13.6 | 1.3 | 36.2% | 11.6% |
SFZN SW Siegfried Holding |
-0.06% | 6.99% | 104% | 24.1 | 22.1 | 1.41 | 66.7% | 72.5% |
SUPN NASDAQ Supernus Pharmaceuticals |
-2.51% | 9.93% | 64.6% | 24 | 20.2 | 1.47 | -20.8% | -17% |
NOVN SW Novartis |
-5.46% | 6.5% | 35.4% | 18.8 | 13.5 | 1.29 | 36.2% | 11.2% |
SOBI ST Swedish Orphan Biovitrum |
-4.14% | -1.14% | 45.8% | 23.6 | 19.5 | 1.5 | 11.8% | 14.7% |
SAN PA Sanofi |
-11% | 4.99% | 19.7% | 21.2 | 11 | 0.88 | -22.1% | -24.8% |
Performance Comparison: TUB vs XLV vs S&P 500
XLV (Health Care Sector SPDR ETF) is the Sector Benchmark for TUB
Total Return (including Dividends) | TUB | XLV | S&P 500 |
---|---|---|---|
1 Month | -12.94% | -4.97% | -4.31% |
3 Months | -21.28% | -6.08% | -7.85% |
12 Months | 28.35% | 0.26% | 10.76% |
5 Years | 78.92% | 47.01% | 106.31% |
Trend Score (consistency of price movement) | TUB | XLV | S&P 500 |
1 Month | -61.7% | -54.4% | -35.6% |
3 Months | -93.0% | -66.1% | -89.7% |
12 Months | 69.0% | -12% | 58.3% |
5 Years | 31.8% | 90% | 84.2% |
Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XLV | vs. S&P 500 |
1 Month | #134 | -8.39% | -9.02% |
3 Month | #123 | -16.2% | -14.6% |
12 Month | #31 | 28.0% | 15.9% |
5 Years | #24 | 21.7% | -13.3% |
FAQs
Does TUB Tubize-Fin outperforms the market?
Yes,
over the last 12 months TUB made 28.35%, while its related Sector, the Health Care Sector SPDR (XLV) made 0.26%.
Over the last 3 months TUB made -21.28%, while XLV made -6.08%.
Over the last 3 months TUB made -21.28%, while XLV made -6.08%.
Performance Comparison TUB vs Indeces and Sectors
TUB vs. Indices TUB is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
US S&P 500 | SPY | -0.87% | -8.63% | -13.4% | 17.6% |
US NASDAQ 100 | QQQ | -2.83% | -8.70% | -13.4% | 16.3% |
US Dow Jones Industrial 30 | DIA | 1.20% | -7.16% | -13.6% | 21.4% |
German DAX 40 | DAX | 1.79% | -9.13% | -31.8% | 4.84% |
Shanghai Shenzhen CSI 300 | CSI 300 | 5.66% | -9.44% | -11.9% | 19.7% |
Hongkong Hang Seng | HSI | 1.40% | -10.1% | -15.2% | 14.3% |
India NIFTY 50 | INDA | 6.56% | -14.5% | -15.0% | 26.6% |
Brasil Bovespa | EWZ | -0.62% | -14.9% | -17.9% | 33.9% |
TUB vs. Sectors TUB is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
Communication Services | XLC | -0.73% | -7.36% | -22.1% | 5.95% |
Consumer Discretionary | XLY | -3.22% | -8.90% | -16.5% | 14.0% |
Consumer Staples | XLP | 6.59% | -15.7% | -18.7% | 18.9% |
Energy | XLE | 2.48% | -1.31% | -10.9% | 40.3% |
Financial | XLF | 1.09% | -8.16% | -21.5% | 9.05% |
Health Care | XLV | 2.15% | -7.97% | -11.4% | 28.1% |
Industrial | XLI | 0.96% | -8.87% | -13.7% | 21.4% |
Materials | XLB | 2.38% | -8.43% | -6.47% | 33.7% |
Real Estate | XLRE | 3.96% | -11.0% | -11.2% | 13.2% |
Technology | XLK | -4.68% | -8.42% | -8.49% | 22.1% |
Utilities | XLU | 3.28% | -14.6% | -16.5% | 7.91% |
Aerospace & Defense | XAR | -0.43% | -12.6% | -24.6% | 1.37% |
Biotech | XBI | - | -5.10% | -0.27% | 30.6% |
Homebuilder | XHB | 0.88% | -6.92% | 1.62% | 36.3% |
Retail | XRT | 1.92% | -10.0% | -9.24% | 32.0% |